774
Participants
Start Date
November 30, 2015
Primary Completion Date
February 5, 2017
Study Completion Date
March 10, 2017
Omadacycline
Injection for IV; Oral tablets
Moxifloxacin
IV solution; Oral tablets
Site 506, Buffalo
Site 516, Huntington
Site 514, Birmingham
Site 501, Mobile
Site 509, Dayton
Site 503, Detroit
Site 520, Saint Paul
Site 512, St Louis
Site 511, Zachary
Site 508, Laguna Hills
Site 505, Ventura
Site 513, Stamford
Site 220, Liège
Site 276, Belo Horizonte
Site 277, Passo Fundo
Site 274, Porto Alegre
Site 279, São José do Rio Preto
Site 305, Kyustendil
Site 303, Pernik
Site 304, Plovdiv
Site 306, Sliven
Site 301, Sofia
Site 302, Sofia
Site 307, Sofia
Site 250, Požega
Site 205, Slavonski Brod
Site 212, Zadar
Site 201, Zagreb
Site 202, Zagreb
Site 203, Zagreb
Site 251, Zagreb
Site 405, Zagreb
Site 412, Kyjov
Site 410, Prague
Site 411, Prague
Site 414, Třebíč
Site 392, T'bilisi
Site 390, Tbilisi
Site 391, Tbilisi
Site 393, Tbilisi
Site 394, Tbilisi
Site 415, Heidelberg
Site 416, Jena
Site 417, Paderborn
Site 207, Athens
Site 420, Athens
Site 210, Athens
Site 421, Athens
Site 208, Thessaloniki
Site 310, Budapest
Site 311, Budapest
Site 312, Budapest
Site 314, Debrecen
Site 316, Miskolc
Site 313, Nyíregyháza
Site 315, Székesfehérvár
Site 213, Holon
Site 214, Nazareth
Site 217, Petah Tikva
Site 215, Ramat Gan
Site 216, Safed
Site 322, Daugavpils
Site 323, Liepāja
Site 320, Riga
Site 321, Riga
Site 228, Guadalajara
Site 472, Guadalajara
Site 227, Monterrey
Site 471, Monterrey
Site 230, Xalapa
Site 234, Cusco
Site 233, Lima
Site 236, Lima
Site 238, Lima
Site 239, Lima
Site 481, Lima
Site 237, Trujillo
Site 555, Caloocan City
552, Iloilo City
554, Manila
Site 551, Quezon City
Site 553, Quezon City
Site 332, Chrzanów
Site 333, Katowice
Site 330, Lodz
Site 331, Wroclaw
Site 334, Łęczna
Site 344, Brasov
Site 340, Bucharest
Site 342, Bucharest
Site 343, Bucharest
Site 345, Craiova
Site 341, Timișoara
352, Moscow
Site 350, Moscow
Site 351, Moscow
Site 353, Saint Petersburg
Site 354, Saint Petersburg
Site 355, Saint Petersburg
Site 356, Saint Petersburg
357, Sestroretsk
Site 358, Vsevolozhsk
Site 359, Zelenograd
Site 431, Bratislava
Site 430, Levice
Site 432, Martin
Site 433, Nitra
Site 241, Benoni
Site 436, Centurion
Site 242, Pretoria
Site 244, Thabazimbi
Site 245, Middelburg
Site 437, Somerset West
Site 293, Daegu
Site 291, Seoul
Site 292, Seoul
Site 294, Seoul
Site 225, Elche
Site 221, Barcelona
Site 440, Barcelona
Site 224, Alzira
Site 226, Alicante
Site 299, Kaohsiung City
Site 297, Tainan City
Site 295, Taipei
Site 296, Taipei
Site 298, Taipei
Site 247, Ankara
Site 248, Ankara
Site 249, Ankara
Site 246, Trabzon
Site 380, Dnipro
Site 373, Dnipropetrovsk
Site 374, Kharkiv
Site 375, Kharkiv
Site 370, Kyiv
Site 372, Kyiv
Site 378, Kyiv
Site 379, Kyiv
Site 376, Zaporizhia
Lead Sponsor
Paratek Pharmaceuticals Inc
INDUSTRY